The FDA approves Apotex Corp.'s plan to introduce generic Ozempic, a semaglutide injection that one study suggests could someday cost as little as $3 a month. Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price cuts to defend Ozempic, Wegovy. Days after semaglutide, the molecule behind blockbuster weight-loss drugs, went off patent in India, prices dropped sharply as multiple generic versions entered the market.

Understanding the Context

Will this lead to wider ... Fortune India: Novo Nordisk withstands stiff generic competition post semaglutide patent expiry in India in March; 26 brands from 13 firms launched Danish drug major Novo Nordisk seems to be withstanding stiff competition from generic players after its global blockbuster diabetes and weight loss drug semaglutide lost patent protection in India on ... Novo Nordisk withstands stiff generic competition post semaglutide patent expiry in India in March; 26 brands from 13 firms launched ET Now on MSN: Weightloss drug, light on pocket! Dr Reddy’s gets nod for generic oral semaglutide; More cheaper anti-diabetic medicines to hit market Semaglutide is an anti-diabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management.

Key Insights

Notably, Torrent Pharma's generic oral ... Weightloss drug, light on pocket! Dr Reddy’s gets nod for generic oral semaglutide; More cheaper anti-diabetic medicines to hit market The Hindu BusinessLine: MSN Laboratories launches semaglutide generic, Semabest in domestic market MSN Laboratories launches Semabest, a generic semaglutide priced 50% lower than the innovator, enhancing diabetes treatment accessibility. The Hindu BusinessLine: Orbicular gets USFDA’s tentative nod for generic Semaglutide Injection in partnership with Apotex Orbicular receives USFDA tentative approval for generic Semaglutide Injection, partnering with Apotex for U.S. commercialization.

Final Thoughts

Orbicular gets USFDA’s tentative nod for generic Semaglutide Injection in partnership with Apotex ET Now on MSN: Dr Reddy's share price: Citi trims target after setback in semaglutide generic